Cargando…
Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A
Relapse is associated with therapy resistance and is a major cause of death in acute myeloid leukemia (AML). It is thought to result from the accretion of therapy-refractory leukemic stem cells. Genetic and transcriptional changes that are recurrently gained at relapse are likely to contribute to th...
Autores principales: | Grandits, Alexander M., Wieser, Rotraud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612147/ https://www.ncbi.nlm.nih.gov/pubmed/34029637 http://dx.doi.org/10.1016/j.exphem.2021.05.004 |
Ejemplares similares
-
CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
por: Gluexam, Tobias, et al.
Publicado: (2019) -
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness
por: Grandits, Alexander Michael, et al.
Publicado: (2021) -
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
por: Larrue, Clément, et al.
Publicado: (2021) -
All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells
por: Nguyen, Chi H., et al.
Publicado: (2020) -
Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia
por: Hackl, Hubert, et al.
Publicado: (2017)